Published in
Elsevier, Contemporary Clinical Trials Communications, (19), p. 100629, 2020
DOI: 10.1016/j.conctc.2020.100629
Links
Tools
Design and rationale of FLAVOUR: A phase IIa efficacy study of the 5-lipoxygenase activating protein antagonist AZD5718 in patients with recent myocardial infarction
Journal article published in 2020 by
Eva Prescott 
,
John Pernow,
Antti Saraste ,
Axel Åkerblom,
Oskar Angerås,
David Erlinge,
Erik L. Grove ,
Marja Hedman,
Lisette O. Jensen,
Sara Svedlund,
Magnus Kjaer ,
Maria Lagerström-Fermér ,
Li-Ming Gan
,
John Pernow,
Antti Saraste ,
Axel Åkerblom,
Oskar Angerås,
David Erlinge,
Erik L. Grove ,
Marja Hedman,
Lisette O. Jensen,
Sara Svedlund,
Magnus Kjaer ,
Maria Lagerström-Fermér ,
Li-Ming Gan
This paper is made freely available by the publisher.
Full text: Download
Data provided by 